TLA Titan Logix Corp

CML HealthCare Inc. (TSX:CLC) (the "Company" or "CML"), a leading
community-based provider of laboratory and medical imaging services in Ontario
and British Columbia, and BD (Becton, Dickinson and Company) ("BD"), a leading
global medical technology company, today announced an agreement for CML to
install two BD Kiestra(TM) Total Laboratory Automation ("TLA") systems. This
fully automated microbiology system will be installed at CML's central
laboratory by the third quarter of 2013. The BD Kiestra(TM) TLA system is
designed to significantly increase overall microbiology lab productivity,
streamline workflow, and shorten the time to results.


"We are very excited to be the first laboratory services provider in North
America to be installing the BD Kiestra(TM) Total Laboratory Automation system.
With our central laboratory processing approximately three million microbiology
tests annually, this installation will be the largest in the world for the BD
Kiestra(TM) TLA system," said Thomas Wellner, President and CEO of CML. "The
implementation of the BD Kiestra(TM) TLA system will allow CML to increase our
capacity, reduce result turnaround times, and contribute to the growth of our
core laboratory business. It will provide us with a significant competitive
advantage and support a key pillar of our growth strategy which is to establish
innovative hospital and other partnerships."


BD Kiestra(TM) TLA system automates the manual processes associated with
inoculating and incubating microbiology specimens, and uses digital imaging of
the inoculated specimens to shorten the time to detect bacterial growth. The
increased efficiency, and quality improvements associated with automation allow
for faster delivery of more accurate results to provide optimal patient care. In
addition, laboratory staff is able to devote more time to analytical and
value-added tasks.


"BD is proud to be working with CML HealthCare Inc., one of Canada's largest and
most forward looking laboratory services provider," said Tom Polen, President BD
Diagnostics - Diagnostic Systems. "Rapid diagnosis and treatment of infections
is critical; however, many of the traditional testing protocols take two or
three days to generate an actionable result. Using the BD Kiestra(TM) TLA
system, integrated with other rapid diagnostic technologies, CML will be a
pioneer in implementing technology that can often reduce those times
significantly. We expect this to enable clinicians to provide patients with the
most effective treatment earlier - thus improving the standard of care and
avoiding unnecessary healthcare costs."


The BD Kiestra(TM) TLA System currently has an installation base of instruments
at public hospitals, universities, and privately owned laboratories in more than
eleven countries worldwide since its introduction in 2006.


About CML HealthCare Inc.

Based in Mississauga, Ontario, CML HealthCare Inc. is a leading community-based,
medical diagnostic services provider in Canada operating 114 Client C.A.R.E.
Centres in Ontario, 84 imaging centres in Ontario and British Columbia, and a
reference laboratory in Ontario focused on specialized coagulation testing and
equipment calibration for international customers. CML is publicly-traded on the
Toronto Stock Exchange under the symbol "CLC" and has approximately 89.8 million
common shares outstanding. For more information, please visit
www.cmlhealthcare.com or follow CML on Twitter @cmlhealthcare.


About BD

BD is a leading global medical technology company that develops, manufactures
and sells medical devices, instrument systems and reagents. The Company is
dedicated to improving people's health throughout the world. BD is focused on
improving drug delivery, enhancing the quality and speed of diagnosing
infectious diseases and cancers, and advancing research, discovery and
production of new drugs and vaccines. BD's capabilities are instrumental in
combating many of the world's most pressing diseases. Founded in 1897 and
headquartered in Franklin Lakes, New Jersey, BD employs nearly 30,000 associates
in more than 50 countries throughout the world. The Company serves healthcare
institutions, life science researchers, clinical laboratories, the
pharmaceutical industry and the general public. For more information, please
visit www.bd.com.   


FOR FURTHER INFORMATION PLEASE CONTACT: 
CML HealthCare Inc.
Alice Dunning, MBA, CFA
Director, Corporate Communications
(905) 565-0043 ext. 3472
(905) 565-2844 (FAX)
DunningA@cml.ca
www.cmlhealthcare.com


BD Public Relations
Jamie Yacco
(201) 847-4796
Jamie_Yacco@bd.com
www.bd.com

Titan Logix (TSXV:TLA)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024

Titan Logix (TSXV:TLA)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024